Inventor · disambiguated record
Caroline Ekblad
Also filed as: EKBLAD CAROLINE
10 granted patents·7 pending applications·24 citations·filing 2011–2020
84Inventor score
Top patents by PatentIndex Score
17 records- 0184US9211344B2PolypeptidesEKBLAD CAROLINE·Filed 2011·Granted Dec 15, 2015·11 cites·45 claims
- 0274US10323066B2Neonatal Fc receptor binding dimer and methods of useAFFIBODY AB·Filed 2015·Granted Jun 18, 2019·2 cites·23 claims
- 0374US9382304B2Engineered polypeptides having enhanced duration of action with reduced immunogenicityERICKSON MARY·Filed 2012·Granted Jul 5, 2016·6 cites·11 claims
- 0471US9975943B2PolypeptidesAFFIBODY AB·Filed 2014·Granted May 22, 2018·2 cites·46 claims
- 0570US10155792B2Albumin binding polypeptideAFFIBODY AB·Filed 2013·Granted Dec 18, 2018·2 cites·24 claims
- 0670US9879063B2Engineered polypeptides having enhanced duration of action and reduced immunogenicityAEGERION PHARMACEUTICALS INC·Filed 2015·Granted Jan 30, 2018·1 cites·14 claims
- 0760US2020199197A1PolypeptidesAFFIBODY AB·Filed 2020·Application pending·0 cites
- 0858US2019031727A1Oral administrationAFFIBODY AB·Filed 2018·Application pending·0 cites
- 0958US2019375799A1PolypeptidesAFFIBODY AB·Filed 2019·Application pending·0 cites
- 1053US10562955B2PolypeptidesAFFIBODY AB·Filed 2017·Granted Feb 18, 2020·0 cites·47 claims
- 1152US10329331B2PolypeptidesAFFIBODY AB·Filed 2015·Granted Jun 25, 2019·0 cites·60 claims
- 1252US2018305430A1Engineered Polypeptides Having Enhanced Duration of Action and Reduced ImmunogenicityAEGERION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1351US2016009767A9Oral administrationAFFIBODY AB·Filed 2013·Application pending·0 cites
- 1449US2019284241A1Neonatal Fc Receptor Binding Dimer and Methods of UseAFFIBODY AB·Filed 2019·Application pending·0 cites
- 1547US10167322B2Engineered albumin binding polypeptideAFFIBODY AB·Filed 2014·Granted Jan 1, 2019·0 cites·19 claims
- 1644US11505576B2Polypeptides based on a scaffoldAFFIBODY AB·Filed 2019·Granted Nov 22, 2022·0 cites·18 claims
- 1736US2018344813A1Engineered polypeptides having enhanced duration of action with reduced immunogenicityERICKSON MARY·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →